NCT06435546

Adherence to Oral Therapies in Advanced Breast and Prostate Cancers

Adherence to Oral Therapies in Advanced Breast and Prostate Cancers: a Pilot Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (actual)
• Sponsor: Institut de Cancérologie de Lorraine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

AdOTAC is a pilot study, open, prospective, single-center, one-arm. The 200 patients will be included. Patient is included at Day 0. The included patient will have the opportunity to complete the self-questionnaires either at the ICL on Day 0, or at home up to 10 days after the date of inclusion in the study. Blood samples are collected the day of enrolment (Day 0) in order to measure the following biological markers: ferritin, serum iron, TSAT, albumin, and haemoglobin, except if performed as part of routine care in the previous 6 weeks.

Conditions

• Breast Cancer
• Prostate Cancer

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Blood samples	Ferritin, Transferrin Saturation (TSAT), Serum iron, Haemoglobin, Albumin
OTHER	Adherence to anti-cancer therapies questionnaires	GIRERD questionnaire, AdOT questionnaire, Use of social networks and alternatives and complementary medicines using patient questionnaire, EORTC QLQC30, HADS, MNA, MSPSS

Timeline

• Start date: 2024-06-04
• Primary completion: 2025-12-12
• Completion: 2025-12-12
• First posted: 2024-05-30
• Last updated: 2026-03-27

Locations

1 site across 1 country: France